Home Association of cathepsin E with tumor growth arrest through angiogenesis inhibition and enhanced immune responses
Article
Licensed
Unlicensed Requires Authentication

Association of cathepsin E with tumor growth arrest through angiogenesis inhibition and enhanced immune responses

  • Masashi Shin , Tomoko Kadowaki , Jun-ichi Iwata , Tomoyo Kawakubo , Noriko Yamaguchi , Ryosuke Takii , Takayuki Tsukuba and Kenji Yamamoto
Published/Copyright: November 2, 2007
Biological Chemistry
From the journal Volume 388 Issue 11

Abstract

Cathepsin E (CE) is an intracellular aspartic proteinase implicated in various physiological and pathological processes, yet its actual roles in vivo remain elusive. To assess the physiological significance of CE expression in tumor cells, human CE was stably expressed in human prostate carcinoma ALVA101 cells expressing very little CE activity. Tumor growth in nude mice with xenografted ALVA101/hCE cells was slower than with control ALVA101/mock cells. Angiogenesis antibody array and ELISA assay showed that this was partly due to the increased expression of some antiangiogenic molecules including interleukin 12 and endostatin in tumors induced by CE expression. In vitro studies also demonstrated that, among the cathepsins tested, CE most efficiently generated endostatin from the non-collagenous fragment of human collagen XVIII at mild acidic pH. Histological examination revealed that tumors formed by ALVA101/hCE cells were partitioned by well-developed membranous structures and covered with thickened, well-stratified hypodermal tissues. In addition, both the number and extent of activation of tumor-infiltrating macrophages were more profound in ALVA101/hCE compared to ALVA101/mock tumors. The chemotactic response of macrophages to ALVA101/hCE cells was also higher than that to ALVA/mock cells. These results thus indicate that CE expression in tumor cells induces tumor growth arrest via inhibition of angiogenesis and enhanced immune responses.


Corresponding author

Received: 2007-6-7
Accepted: 2007-8-8
Published Online: 2007-11-02
Published in Print: 2007-11-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Proteinase Inhibitors and Biological Control – An Attractive International Symposia Series
  2. Two decades of thyroglobulin type-1 domain research
  3. Cysteine cathepsin non-inhibitory binding partners: modulating intracellular trafficking and function
  4. Cysteine proteases: destruction ability versus immunomodulation capacity in immune cells
  5. ‘Species’ of peptidases
  6. Protease research in the era of systems biology
  7. Human and mouse homo-oligomeric meprin A metalloendopeptidase: substrate and inhibitor specificities
  8. Association of cathepsin E with tumor growth arrest through angiogenesis inhibition and enhanced immune responses
  9. Characterization and comparative 3D modeling of CmPI-II, a novel ‘non-classical’ Kazal-type inhibitor from the marine snail Cenchritis muricatus (Mollusca)
  10. Cellular localization of MAGI-1 caspase cleavage products and their role in apoptosis
  11. Differential methylation kinetics of individual target site strands by T4Dam DNA methyltransferase
  12. Characterisation of zinc-binding domains of peroxisomal RING finger proteins using size exclusion chromatography/inductively coupled plasma-mass spectrometry
  13. Defining the extended substrate specificity of kallikrein 1-related peptidases
  14. Latent MMP-9 is bound to TIMP-1 before secretion
  15. Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma
  16. Activity of ulilysin, an archaeal PAPP-A-related gelatinase and IGFBP protease
  17. Clinical chemistry reference database for Wistar rats and C57/BL6 mice
Downloaded on 21.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2007.154/html
Scroll to top button